NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
A Prior Information Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- 2 year
- Value
- £0-£196M
- Sector
- HEALTH
- Published
- 23 Jan 2026
- Delivery
- 01 Jun 2026 to 31 May 2028
- Deadline
- n/a
Related Terms
Location
1 buyer
- NHS England London
Description
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– Hospital Only Products - Lenalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028 CM/PHG/24/5716/02 – Hospital Only Products - Pomalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028 CM/PHG/24/5716/03 – Hospital Only Products - Thalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Renewals are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-051c39
- FTS 006070-2026